Clinician Summary

Displaying 1 - 12 out of 12 topics found with matching tool types

    Brain Injury and Brain Death

  1. Practice guideline: Reducing brain injury after cardiopulmonary resuscitation

    May 2017

  2. Summary of Evidence-based Guideline Update: Evaluation and Management of Concussion in Sports

    March 2013

  3. Update: Determining Brain Death in Adults

    June 2010

  4. Update: Determining Brain Death in Adults

    June 2010

    Practical guidance document.

  5. Update: Determining Brain Death in Adults

    June 2010

    Ancillary testing document.

  6. Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation

    July 2006

  7. Child Neurology

  8. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis

    October 2016

  9. Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy

    February 2016

  10. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

    March 2015

  11. Summary of Evidence-based Guideline Update: Evaluation and Management of Concussion in Sports

    March 2013

  12. Update: Medical Treatment of Infantile Spasms

    June 2012

  13. Evidence Report: Genetic and Metabolic Testing on Children with Global Developmental Delay

    October 2011

  14. Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy

    January 2010

  15. Evaluation of the child with microcephaly

    September 2009

  16. Diagnostic Assessment of the Child with Status Epilepticus

    November 2006

  17. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

  18. Diagnostic Assessment of the Child with Cerebral Palsy

    March 2004

  19. Evaluation of the Child with Global Developmental Delay

    February 2003

  20. Screening and Diagnosis of Autism

    August 2000

  21. Dementia

  22. Practice Guideline Update Summary: Mild Cognitive Impairment

    December 2017

  23. Diagnostic Accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease

    October 2012

  24. Update: Evaluation and Management of Driving Risk in Dementia

    April 2010

  25. Diagnosis of Dementia

    May 2001

  26. Endorsed or Affirmed Statements

  27. Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department

    February 2013

  28. Epilepsy

  29. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors

    April 2017

  30. Practice Guideline Summary: Use of fMRI in the Presurgical Evaluation of Patients with Epilepsy

    January 2017

  31. Evidence-based Guideline: Management of an Unprovoked First Seizure in Adults

    April 2015

  32. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  33. Treatment of Parenchymal Neurocysticercosis

    October 2013

    Spanish-language version.

  34. Update: Vagus Nerve Stimulation for the Treatment of Epilepsy

    August 2013

  35. Treatment of Parenchymal Neurocysticercosis

    April 2013

  36. Update: Medical Treatment of Infantile Spasms

    June 2012

  37. Antiepileptic Drug Selection for People with HIV/AIDS

    January 2012

    African French

  38. Update: Management issues for women with epilepsy-focus on pregnancy: Teratogenesis and perinatal outcomes

    July 2009

  39. Update: Management issues for women with epilepsy-focus on pregnancy: Obstetrical complications and change in seizure frequency

    April 2009

  40. Update: Management issues for women with epilepsy-focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding

    April 2009

  41. Evaluating an apparent unprovoked first seizure in adults

    November 2007

  42. Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure

    October 2007

  43. Diagnostic Assessment of the Child with Status Epilepticus

    November 2006

  44. Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy

    April 2004

  45. Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment of Refractory Epilepsy

    April 2004

  46. Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment of Refractory Epilepsy

    April 2004

  47. Headache

  48. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  49. Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults

    April 2012

  50. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

  51. Movement Disorders

  52. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

  53. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  54. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  55. Treatment of Tardive Syndromes

    July 2013

  56. Pharmacologic Treatment of Chorea in Huntington Disease

    August 2012

  57. Update: Treatment of Essential Tremor

    October 2011

  58. Treatment of Nonmotor Symptoms of Parkinson Disease

    March 2010

  59. Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease

    April 2006

  60. Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesias

    April 2006

  61. Multiple Sclerosis

  62. Summary of Comprehensive Systematic Review: Rehabilitation in Multiple Sclerosis

    November 2015

  63. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  64. Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis

    March 2014

  65. Assessment and Management of Psychiatric Disorders in Individuals with Multiple Sclerosis

    December 2013

  66. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

  67. Neutralizing Antibodies to Interferon-beta: Assessment of their Clinical and Radiographic Impact

    August 2007

  68. Neuromuscular

  69. Practice advisory: Etanercept for poststroke disability

    June 2016

  70. Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy

    February 2016

  71. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Facioscapulohumeral Muscular Dystrophy

    July 2015

  72. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

    March 2015

  73. Evidence-based Guideline Summary: Diagnosis and Treatment of Limb-girdle and Distal Dystrophies

    October 2014

  74. Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders

    March 2012

  75. Update: Intraoperative Spinal Monitoring with Somatosensory and Transcranial Electrical Motor Evoked Potentials

    February 2012

  76. Treatment of Painful Diabetic Neuropathy

    April 2011

  77. Symptomatic Treatment for Muscle Cramps

    February 2010

  78. Update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies

    October 2009

  79. Update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment

    October 2009

  80. Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy

    January 2009

  81. Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing

    January 2009

  82. Utility of Surgical Decompression for Treatment of Diabetic Neuropathy

    June 2006

  83. Immunotherapy for Guillain-Barre Syndrome

    September 2003

  84. Other

  85. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

  86. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  87. Update: Steroids and Antivirals for Bell Palsy

    November 2012

  88. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

  89. The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia

    October 2008

  90. Therapies for benign paroxysmal positional vertigo

    May 2008

  91. Assessing Patients In A Neurology Practice For Risk Of Falls

    February 2008

  92. Use of epidural steroid injections to treat radicular lumbosacral pain

    August 2007

  93. Treatment of Nervous System Lyme Disease

    July 2007

  94. Treatment of Postherpetic Neuralgia

    September 2004

  95. Stroke and Vascular Neurology

  96. Practice Advisory: Recurrent Stroke with Patent Foramen Ovale (Update of Practice Parameter)

    July 2016

  97. Practice advisory: Etanercept for poststroke disability

    June 2016

  98. Summary of Evidence-based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation

    February 2014

  99. Periprocedural Management of Antithrombotic Medications in Patients with Ischemic Cerebrovascular Disease

    May 2013

  100. Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department

    February 2013

  101. The Role of Diffusion and Perfusion MRI for the Diagnosis of Acute Ischemic Stroke

    July 2010

  102. Carotid Endarterectomy

    September 2005

  103. Recurrent Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm

    April 2004

  104. Technology Assessments

  105. Practice Guideline: Cervical and Ocular Vestibular Evoked Myogenic Potential Testing

    November 2017

  106. Practice Guideline Summary: Use of fMRI in the Presurgical Evaluation of Patients with Epilepsy

    January 2017

  107. Practice advisory: The utility of EEG theta/beta power ratio in ADHD diagnosis

    October 2016

  108. Practice Guideline: Idiopathic Normal Pressure Hydrocephalus: Response to Shunting and Predictors of Response

    December 2015

  109. Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders

    March 2012

  110. Update: Intraoperative Spinal Monitoring with Somatosensory and Transcranial Electrical Motor Evoked Potentials

    February 2012

  111. Update: Plasmapheresis in Neurologic Disorders

    January 2011

  112. Efficacy of Transcutaneous Electric Nerve Stimulation in the Treatment of Pain in Neurologic Disorders

    January 2010

  113. Botulinum neurotoxin for the treatment of movement disorders

    May 2008

  114. Botulinum neurotoxin in the treatment of autonomic disorders and pain

    May 2008

  115. Botulinum neurotoxin for the treatment of spasticity

    May 2008

  116. Carotid Endarterectomy

    September 2005

  117. Transcranial Doppler Ultrasonography UPDATED

    May 2004

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer